Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease

Circulation

Volumn 95, Issue 8, 1997, Pages 2068-2074

  Böger, Rainer H ^a   Bode Böger, Stefanie M ^b   Thiele, Wolfgang ^b   Junker, Wolfgang ^b   Alexander, Klaus ^a   Frölich, Jürgen C ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Hannover Medical School ^*

Author keywords

atherosclerosis; endothelium derived factors; hypercholesterolemia; risk factors

Indexed keywords

CREATININE; CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0242640310     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.8.2068     Document Type: Article

References (38)

1. Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
2. Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H. Nitric oxide synthase isoenzymes: characterization, purification, molecular cloning, and functions. Hypertension. 1994; 23:1121-1131.
3. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 1991;83:1057-1062.
4. Böger RH, Bode-Böger SM, Mügge A, Kienke S, Brandes R, Dwenger A, Frölich JC. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995;117: 273-284.
5. Kubes P, Suzuki M, Ganger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991; 88:4651-4655.
6. Lefer AM, Ma XI. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb. 1993;13:771-776.
7. Tsao PS, Theilmeier G, Singer AH, Leung LLK, Cooke JP. L-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:1529-1533.
8. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherosclerotic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
9. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol. 1992;20(suppl 12):S60-S62.
10. Yu X, Li Y, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci. 1994;54:753-758.
11. Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhancedsystemicNOproductionbydietaryL-arginineinhypercholesterolemic rabbits. Biochem Biophys Res Commun 1996;219: 598-603.
12. Wennmalm A, Benthin G, Edlund A. Jungersten L, Kieler-Jensen N, Lundin S, Nathorst Westfelt U, Petersson AS, Waagstein F. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circulation. 1993;73:1121-1127.
13. Böger RH, Bode-Böger SM, Gerecke U, Frölich JC. Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulate urinary nitrate and cyclic GMP excretion in rats: correlation with vascular reactivity. Cardiovasc Res. 1994;28:494-499.
14. - excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-NAME in rats. Clin Exp Pharmacol Physiol. 1996;23:11-15.
15. Bode-Böger SM, Böger RH, Schröder EP, Frölich JC. Exercise increases systemic NO production in men. J Cardiovasc Risk. 1994; 1:173-178.
16. 15N-labelled analogs. J Chromatogr B. 1994;661: 185-191.
17. Bode-Böger SM, Böger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frölich JC. L-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia: a randomized, controlled study. Circulation. 1996;93:85-90.
18. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-1051.
19. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991;338:1546-1550.
20. Creager MA, Cooke JP, Mendelson ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
21. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Role of nitric oxide in the endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
22. Böger RH, Bode-Böger SM, Frölich JC. The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis. 1996;127:1-11.
23. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995;270:319-324.
24. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993,91:2546-2551.
25. Mügge A, Brandes R, Böger RH, Dwenger A, Bode-Böger SM, Kienke S, Frölich JC, Lichtlen PR. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol. 1994;24:994-998.
26. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109-2116.
27. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 1990;30:535-560.
28. Lang D, Smith JA, Lewis MJ. Induction of a calcium-independent NO synthase by hypercholesterolaemia in the rabbit. Br J Pharmacol. 1993;108:290-292.
29. Pomerantz KB, Hajjar DP, Levi R, Gross SS. Cholesterol enrichment of arterial smooth muscle cells upregulates cytokine-induced nitric oxide synthesis. Biochem Biophys Res Commun. 1993; 191:103-109.
30. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
31. G dimethylarginine by human endothelial cells. Endothelium. 1993;1:137-140.
32. Kurose I, Wolf R, Grisham MB, Granger DN. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am J Physiol. 1995;268:H2224-H2231.
33. Faraci FM, Brian JE, Heistad DD. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol. 1995;269:H1522-H1527.
34. G-dimethylarginine in the rabbit. Biochem J. 1976;154:179-184.
35. McAllister RJ, Fickling SA, Whitley GSJ, Vallance P. Metabolism of methylarginines by human vasculature: implications for the regulation of nitric oxide synthesis. Br J Pharmacol. 1994;112:43-48.
36. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90: 1248-1253.
37. Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M, Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991;88:10480-10484.
38. D'Orleans-Juste P, Mitchell JA, Wood EG, Hecker M, Vane JR. Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells. Can J Physiol Pharmacol. 1992;70:687-694.